M&T Bank
PACB icon

M&T Bank’s Pacific Biosciences PACB Stock Holding History

M&T Bank’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,560
Closed -$52K – 2209
2014
Q3 		$52K Buy
+10,560
New +$55.2K ﹤0.01% 2082

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MMC
MDV Management Company Menlo Park, California $296M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's PACB Position: Q4 2014 in Review

M&T Bank sold out of Pacific Biosciences (PACB) in Q4 2014, closing a stake of 10,560 shares — an estimated $52K sold.

M&T Bank first reported a position in PACB in Q3 2014 and held it in 1 quarter. The position peaked at $52K in Q3 2014. 101 funds tracked by Wall St. Rank hold PACB as of Q4 2014.

  • M&T Bank reported no remaining Pacific Biosciences position as of Q4 2014 after selling out during the quarter.
  • M&T Bank sold 10,560 Pacific Biosciences shares in Q4 2014, an estimated $52K.
  • M&T Bank first reported a position in Pacific Biosciences in Q3 2014 and held it in 1 quarter.
  • M&T Bank's Pacific Biosciences position peaked at $52K in Q3 2014.
  • 101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2014.

Based on M&T Bank's 13F filing for Q4 2014, filed 12 Feb 2015.